Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trials

A subsidiary of Hansoh Pharmaceutical Group Company Limited

The registry lists 135 studies whose lead sponsor is Jiangsu Hansoh Pharmaceutical Co., Ltd.. 71 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 135. List all 135 → · All Hansoh Pharmaceutical Group Company Limited studies →

• A Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPNot yet recruitingNCT07885293Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506RecruitingNCT07844967Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.Not yet recruitingNCT07836504Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNot yet recruitingNCT07822542Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical CystectomyRecruitingNCT07468851Phase 1/2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)RecruitingNCT06461156Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C LevelsNot yet recruitingNCT07777003Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504Not yet recruitingNCT07770217Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque PsoriasisNot yet recruitingNCT07765628Phase 2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504Not yet recruitingNCT07764692Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Mass Balance Study of [14C]HS-10504Not yet recruitingNCT07764705Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study to Evaluate the Long-term Safety of HS-10380 in Patients With SchizophreniaNot yet recruitingNCT07759869Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCNot yet recruitingNCT07754123Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase I Study of Single and Multiple Doses of HS-20136-2 Injection in Healthy or Obese ParticipantsNot yet recruitingNCT07716241Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung CancerNot yet recruitingNCT07685041Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia DisorderNot yet recruitingNCT07677384Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-20136-2 in Healthy ParticipantsNot yet recruitingNCT07483437Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.Not yet recruitingNCT07615413Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild HypertensionNot yet recruitingNCT07609875Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-10506 in Chinese Patients With Insomnia DisorderNot yet recruitingNCT07587385Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-10587 in Patients With Advanced Solid TumorsNot yet recruitingNCT07567859Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney DiseaseNot yet recruitingNCT07555054Phase 2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult ParticipantsNot yet recruitingNCT07535970Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal HemoglobinuriaRecruitingNCT07470762Phase 1/2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Phase 1 Study of HS-20152 in Healthy ParticipantsNot yet recruitingNCT07503015Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Efficacy and Safety Study of HS-10542 for IgA NephropathyNot yet recruitingNCT07474636Phase 2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase Ib Study of HS-10504 Combined Therapy in NSCLCNot yet recruitingNCT07414953Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise AloneNot yet recruitingNCT07156500Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase 3 Study of HS-20094 in Patients With T2DMNot yet recruitingNCT07156539Phase 3

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of Aumolertinib in European Participants With Non-Small Cell Lung CancerRecruitingNCT07130916Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118RecruitingNCT06846710Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell CarcinomaRecruitingNCT07097935Phase 1/2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-20094 in Overweight or Obese ParticipantsRecruitingNCT07057674Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• HS-10542 Study in Healthy ParticipantsRecruitingNCT07040046Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingNCT06769425Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118RecruitingNCT07033234Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of Hansoh (HS)-10502 in Patients With Advanced Solid TumorsRecruitingNCT05740956Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy SubjectsNot yet recruitingNCT07001787Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsNot yet recruitingNCT06963502Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-10529 in KRAS G12D Patients With Advanced Solid TumorsNot yet recruitingNCT06963398Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLCRecruitingNCT06926413Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.Not yet recruitingNCT06864507Phase 1/2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic FunctionNot yet recruitingNCT06823258Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic FunctionNot yet recruitingNCT06823245Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)RecruitingNCT05435248Phase 1/2

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid TumorsNot yet recruitingNCT06594874Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study Evaluating Food Effect on Pharmacokinetics of HS-10518Not yet recruitingNCT06554548Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• A Study of HS-10516 in Patients With VHL Syndrome Associated TumorsRecruitingNCT06553339Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)Not yet recruitingNCT06530810Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.

• Phase 1 Study in Healthy Participants and Participants With Kidney DysfunctionNot yet recruitingNCT06383897Phase 1

  Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.